Product · Lighting
Product · InnDex 62 · Evidence provided · High specification risk
Wall/ceiling panels emitting spectrally tuned artificial daylight calibrated to circadian rhythms for interior spaces.
Lightglass manufactures mounted luminous panels that deliver melanopic-lux-optimized light to support circadian biology in windowless or light-poor interiors. Targets hospitals, offices, and institutional rooms where natural daylighting is absent or insufficient. The panels emit dynamic spectral output designed to entrain circadian phase and amplitude, addressing documented wellbeing and sleep-disruption gaps in interior environments.
Lightglass produces wall- and ceiling-mounted panels that deliver melanopic-lux-optimised light — spectrally weighted toward the ~480 nm range that drives circadian biology — targeting spaces where windows cannot exist or daylighting is structurally absent, such as hospital treatment rooms, basement offices, and deep-plan institutional interiors. The most credible signal in the record is a documented 23-room deployment in a CHOP hospital wing with architectural recognition, which places this well above purely speculative circadian technology; that is a real institutional reference in a demanding environment where outcomes matter. What remains limited is independent peer-reviewed evidence on long-term circadian efficacy in operational conditions rather than controlled trials, and the broader cost-benefit case against conventional lighting supplemented by behavioural or scheduling interventions has not been established. The panels add capital cost and ongoing power draw to a space that already has base lighting and cannot substitute for it, which is a harder sell for cost-sensitive clients than for healthcare environments where occupant recovery outcomes are a governing design brief. Individual variation in melanopsin response means no single spectral prescription will work optimally for all occupants, and regulatory standards for circadian lighting claims are still nascent. Strongest fit is healthcare and institutional projects with a specific brief for shift-worker or windowless-occupant wellbeing, where the CHOP reference is a useful precedent — in speculative commercial work, the ROI case needs to be made project-by-project.
Pilot/deployed evidence exists (CHOP case study, award, claimed 100+ projects), but no published independent clinical trial data on patient outcomes, no LCA/EPD documentation, no third-party photometry validation, and no disclosure of installed cost or maintenance protocol. WELL L03 compliance claim is plausible based on standard (≥200 EML vertical plane) but unverified by independent testing. Source page was JavaScript form library code—not a content page—suggesting limited online transparency about specs.
#circadian_lighting #human_centric_lighting #melanopic_lux #interior_daylighting #wellness #institutional